BODE Index
Prognostic and 4-year mortality assessment for patients with COPD.
The BODE Index: A Multidimensional Assessment of COPD
Chronic Obstructive Pulmonary Disease (COPD) is a heterogeneous disease whose severity cannot be summarized by the degree of airflow obstruction (FEV1) alone. The BODE Index, developed by Celli and colleagues in 2004, is a multidimensional grading system that incorporates the systemic manifestations of the disease. It has proven to be a better predictor of mortality risk than FEV1 alone.
The 4 Components of the BODE Index
The acronym BODE represents the following elements, each assigned points from 0 to 3 (except BMI, 0 to 1):
- B (Body Mass Index): BMI. Malnutrition and cachexia (BMI ≤ 21) are poor prognostic markers related to the systemic component of COPD.
- O (Airflow Obstruction): Evaluated by post-bronchodilator FEV1 (% of predicted value) measured by spirometry.
- D (Dyspnea): Evaluated by the mMRC scale. The perception of breathlessness limits daily activities.
- E (Exercise Capacity): Evaluated by the distance walked in the 6-Minute Walk Test (6MWT). It reflects exercise tolerance and cardiovascular impact.
Clinical Utility
The BODE score (ranging from 0 to 10) is particularly useful for evaluating the response to interventions such as pulmonary rehabilitation, oxygen therapy, or lung volume reduction surgery. A decrease in the BODE score over time (e.g., after rehabilitation) is a highly encouraging favorable prognostic sign.
Interpretation and 4-Year Mortality
| BODE Score | Quartile | Estimated 4-Year Mortality |
|---|---|---|
| 0 - 2 points | Quartile 1 | Approx. 18% |
| 3 - 4 points | Quartile 2 | Approx. 32% |
| 5 - 6 points | Quartile 3 | Approx. 40% |
| 7 - 10 points | Quartile 4 | Approx. 80% |
References:
1. Celli BR, Cote CG, Marin JM, et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med. 2004;350(10):1005-12. [NEJM]
-
💡 Committed to scientific accuracy, if you notice any clinical or technical discrepancy, please let us know.